A Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment (PVD)
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2019-06-21
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 4
- Registration Number
- NCT00347646
- Locations
- 🇺🇸
University Hospitals of Cleveland, Cleveland, Ohio, United States
A Study to Evaluate the Safety and Effectiveness of the 217z Laser With Zyoptix for Lasik
Not Applicable
Withdrawn
- Conditions
- MyopiaAstigmatism
- Interventions
- Device: 217z Laser
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2011-12-08
- Lead Sponsor
- Bausch & Lomb Incorporated
- Registration Number
- NCT00347997
A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial Conjunctivitis
Phase 3
Completed
- Conditions
- Acute Bacterial Conjunctivitis
- Interventions
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2015-03-24
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 1161
- Registration Number
- NCT00348348
A Study to Evaluate the Safety and Effectiveness of the Technols 217z Zyoptix System for Hyperopia
Not Applicable
Completed
- Conditions
- HyperopiaAstigmatism
- Interventions
- Device: Technolas 217z Zyoptix Laser
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2020-09-14
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 80
- Registration Number
- NCT00348205
- Locations
- 🇺🇸
Bausch & Lomb, Rochester, New York, United States
Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery
Phase 3
Completed
- Conditions
- PainInflammation
- Interventions
- Drug: placebo comparator
- First Posted Date
- 2006-06-06
- Last Posted Date
- 2013-02-15
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 522
- Registration Number
- NCT00333918
Evaluation of Vitrase as an Adjuvant to Increase Absorption and Dispersion of Other Injected Anesthetics
Phase 4
Completed
- Conditions
- Pain
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2013-03-19
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 40
- Registration Number
- NCT00198549
- Locations
- 🇺🇸
Cincinnati Eye Institute, Cincinnati, Ohio, United States
Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2013-03-18
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 65
- Registration Number
- NCT00198458
- Locations
- 🇺🇸
Solano Clinical Research (A Division of Dow Pharmaceutical Sciences), Davis, California, United States
Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2013-03-15
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 750
- Registration Number
- NCT00198510
- Locations
- 🇺🇸
Illinois Retina Associates SC, Chicago, Illinois, United States
🇺🇸Retina Center at Pali Momi, Aiea, Hawaii, United States
🇺🇸King Y. Lee, MD, Shawnee Mission, Kansas, United States
Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2013-03-15
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 10
- Registration Number
- NCT00198471
- Locations
- 🇺🇸
Edgar L. Thomas, MD, Beverly Hills, California, United States
🇺🇸Valley Retina Institute, PA, McAllen, Texas, United States
🇺🇸Ronni Lieberman, MD, New York, New York, United States
Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage
Phase 3
Completed
- Conditions
- Vitreous HemorrhageDiabetic Retinopathy
- Interventions
- Drug: Placebo
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2013-03-15
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 510
- Registration Number
- NCT00198497
- Locations
- 🇿🇦
Nasionale Hospital, Bloemfontein, South Africa
🇵🇱Klinika Chorob Oczu, Bydgoszcz, Poland
🇵🇱Ophtalmology Clinic, Gdansk, Poland
© Copyright 2025. All Rights Reserved by MedPath